Narat Srivali: New Systematic Review and Meta-Analysis on Glucocorticoid Therapy and The Risk of VTE
Narat Srivali, Assistant Professor at Duke University Medical Center, shared on LinkedIn about a recent article he and Federica De Giacomi co-authored, published in Expert Opinion on Pharmacotherapy, adding:
”Excited to share our new systematic review and meta-analysis on glucocorticoid therapy and the risk of venous thromboembolism (VTE).
We found that glucocorticoid use is associated with an approximately 2.6-fold increased risk of VTE, with the highest risk seen early in treatment, at higher doses, and with systemic formulations.
These findings may help clinicians think more carefully about VTE risk stratification when initiating glucocorticoids, especially in patients with additional risk factors.”
Title: Glucocorticoid therapy and risk of venous thromboembolism: a systematic review and meta-analysis with exploration of dose, duration, and route-specific effects
Authors: Narat Srivali, Federica De Giacomi
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?
-
Aug 31, 2026, 14:24Akl Fahed: Do Lifelong Differences in LDL Cholesterol Influence the Risk of Venous Thromboembolism?
-
Aug 31, 2026, 14:23Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
-
Aug 31, 2026, 14:21Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
-
Aug 31, 2026, 14:14Jason Andrade: SINGLE-AF Trial Validates Early Anticoagulation in AF
-
Aug 31, 2026, 14:12Leonardo Roever: Diagnosis and Management of Natural Anticoagulant Deficiencies
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery